PMID: 6111633Mar 7, 1981Paper

A role for prostacyclin (PGi2) in excessive menstrual bleeding

Lancet
S K SmithD T Baird

Abstract

The synthesis of prostanoids from arachidonic acid incubated with endometrium alone or together with myometrium was studied in women with excessive menstrual blood-loss (range 57--186 ml, median 86 ml). Production of prostaglandins F2 alpha, E2, and D2 was similar to that observed for the endometrium of women with normal periods (range 5--50 ml; median 11 ml). However, the endometrium from women with excessive menstrual blood-loss was more effective than endometrium from women with normal menstrual blood-loss at enhancing the production by a control preparation of myometrium of 6-oxo-prostaglandin F1 alpha, the stable metabolite of prostacyclin. The ability of the uterus to generate prostacyclin, a prostaglandin known to inhibit platelet aggregation and stimulate vasodilatation, may influence the degree and duration of menstrual bleeding.

Citations

Jan 1, 1988·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·X L Zheng, L L Lo
Aug 2, 2012·Reviews in Endocrine & Metabolic Disorders·Malcolm G Munro
Mar 1, 1985·Prostaglandins, Leukotrienes, and Medicine·I T CameronD T Baird
Dec 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D T BairdR W Kelly
Oct 2, 2003·Prostaglandins & Other Lipid Mediators·Kurt J Sales, Henry N Jabbour
Sep 1, 1994·British Journal of Pharmacology·E K Naderali, N L Poyser
Nov 13, 2003·Reproduction : the Official Journal of the Society for the Study of Fertility·Kurt J Sales, Henry N Jabbour
Apr 2, 2004·Reproduction : the Official Journal of the Society for the Study of Fertility·S BattersbyHenry N Jabbour
Nov 1, 1982·American Journal of Public Health·N F WoodsG K Dery
Jul 25, 1998·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·C Coll Capdevila
Sep 1, 1986·British Journal of Obstetrics and Gynaecology·L Mäkäräinen, O Ylikorkala
Mar 1, 1986·British Journal of Obstetrics and Gynaecology·L Mäkäräinen, O Ylikorkala
Jul 1, 1984·British Journal of Obstetrics and Gynaecology·M C ReesA C Turnbull
Oct 1, 1988·Prostaglandins, Leukotrienes, and Essential Fatty Acids·R C Bonney, W Wong
Dec 1, 1992·Baillière's Clinical Obstetrics and Gynaecology·I S Fraser
Oct 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·N Chegini, C V Rao
Jun 17, 2000·Obstetrics and Gynecology Clinics of North America·Malcolm G Munro
Jul 20, 2012·The Annals of Pharmacotherapy·Sandra L Hrometz
Feb 5, 2003·Microscopy Research and Technique·M Hickey, I S Fraser
Apr 5, 2005·Clinical Obstetrics and Gynecology·Rameet H Singh, Paul Blumenthal
Mar 1, 1991·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M Barthwal, K Srivastava
Jun 1, 1983·British Journal of Obstetrics and Gynaecology·L Mäkäräinen, O Ylikorkala
Sep 15, 2005·Endocrine Reviews·Henry N JabbourHilary O D Critchley
Jan 1, 1985·Postgraduate Medicine·R C Strickler
Sep 1, 1990·Asia-Oceania Journal of Obstetrics and Gynaecology·V GroverS Kalra
Feb 25, 2011·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Malcolm G MunroFIGO Working Group on Menstrual Disorders
Aug 9, 2015·Human Reproduction Update·Jacqueline A Maybin, Hilary O D Critchley
Mar 16, 2011·Annals of the New York Academy of Sciences·Jacqueline A Maybin, Hilary O D Critchley
Apr 19, 2011·Fertility and Sterility·Malcolm G MunroFIGO Menstrual Disorders Working Group

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.